<DOC>
	<DOCNO>NCT00312533</DOCNO>
	<brief_summary>The goal viscosupplementation replenish synovial fluid , improve patient symptom mobility . Viscosupplementation knee hyaluronic acid injection show improve symptom patient osteoarthritis . Recent study show improvement may highly variable base time treatment , especially first 12 week follow treatment . The purpose study document outcomes follow treatment protocol corticosteroid use addition initial Synvisc injection series three injection .</brief_summary>
	<brief_title>Outcome Following Hylan F- 20 ( Synvisc ) + Corticosteroid Injections Treatment Osteoarthritis Knee</brief_title>
	<detailed_description>Upon initial visit , study patient complete informed consent . After consent , patient complete baseline questionnaire packet , include questionnaire several validate score system . Following injection , patient receive diary document adverse event first second injection . In one week , patient return second visit receive second injection . Again ask maintain diary adverse event follow second injection . The patient receive final injection week 3 complete diary event one week . At 1 week , 3 week , 6 week , 12 week , 26 week follow complete series injection , patient complete form include pain , stiffness , physical function subscales WOMAC score 10 point patient satisfaction question . At 6 month , patient receive mail questionnaire packet receive baseline , addition patient satisfaction subsequent injury/treatment question .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<criteria>Men woman age 18 80 year diagnosis osteoarthritis knee . Diagnosis base radiographic examination ( KellgrenLawrence 2 3 ) previous arthroscopic diagnosis . Surgical treatment osteoarthritis limit arthroscopic surgery include removal loose body , resection unstable meniscus tear loose unstable chondral flap , removal osteophyte limit extension , lysis adhesion . These type treatment may provide symptomatic relief increase joint volume knee osteoarthritis relieve joint contact pressure . Patients grade 4 KellgrenLawrence radiographic examination exclude . Patients prior synovectomy knee inject exclude . Patients exclude rheumatoid disease serious systemic disease , acute synovitis excessive effusion , allergy avian products/hyaluronanbased injection components/corticosteroid injection , pregnant , previous arthroscopic surgery within last 6 month joint infection within previous 3 month . Patients undergone prior synovectomy include .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>knee</keyword>
	<keyword>injection</keyword>
	<keyword>function</keyword>
	<keyword>osteoarthritis</keyword>
</DOC>